Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Pharmacogenet Genomics. 2018 Jan;28(1):7–16. doi: 10.1097/FPC.0000000000000317

Table 1.

Summary of the studies that were used for CYP2A6 sequencing and CYP2A6 genotype-phenotype analyses.

Study Title Number of
subjects analyzed
Sequencing or
Genotyping Approach
Purpose of sequencing
or genotyping
Reference for
original study
Liver Bank 43 CYP2A6-Specific sequencing Exploratory sequencing Tanner, Prasad [17]
Pharmacokinetic Study 57 CYP2A6-Specific sequencing Exploratory sequencing Mwenifumbo, Sellers [24]
KIS2 26 CYP2A6-Specific sequencing Exploratory sequencing Ho, Mwenifumbo [25]
KIS3 86 CYP2A6-Specific sequencing Exploratory sequencing Cox, Nollen [26]
Liver Bank 327 PGRN-Sequencing, and TaqMan SNP genotyping Identify SNPs for genotype-phenotype analyses Tanner, Prasad [17]
PNAT 641 Genotyped via GWAS SNP calls Identify SNPs for genotype-phenotype analyses Lerman, Schnoll [7]